EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Muco-obstructive lung disease exhibits distinct hypoxic and inflammatory airway epithelial gene pathways

Yu Mikami iD, Ella Burns iD, Hong Dang, Catharina van Heusden, Ray A Caldwell, Boris Reidel, Minako Furusho, Hiroaki Murano, Takanori Asakura iD, Martina Gentzsch iD, Mehmet Kesimer, Kenichi Okuda und 4 weitere

European Respiratory Journal · 29.10.2026 · 2502798

DOI: 10.1183/13993003.02798-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 29.10.2026. Verfasst von Yu Mikami und 15 weiteren Autor:innen. Beteiligte Einrichtung: Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, , USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, Japan Agency for Medical Research and Development, National Center for Advancing Translational Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intraluminal obstruction produces chronic airway epithelial hypoxia. We investigated how chronic airway epithelial hypoxia and inflammatory stimuli interact in human bronchial epithelial (HBE) cultures and resected human bronchiectatic lungs to produce an airway epithelial environment characteristic of muco-obstructive disease. Materials and Methods HBE cultures were exposed to normoxia or hypoxia (1% O 2 ) for 5 days, followed by administration of supernatants from cystic fibrosis (CF) lung-derived mucopurulent material (SMM) or PBS for 24 h. A reverse order protocol with SMM followed by hypoxia was also performed. Bulk RNA-sequencing and functional (Na + transport) studies were performed. HIF1A and EPAS1-mediated transcriptional responses were characterised in CRISPR knockdown HBE cells. RNA in situ hybridisation studies of excised bronchiectatic lungs and bioinformatic analyses of published datasets tested for relevance of in vitro findings to in vivo conditions.

Results

Hypoxia and SMM regulated largely separate airway epithelial transcriptional programmes regardless of treatment order. PTGS2 (COX-2), CCL20 , MUC5B , and CXCL8 (IL-8) represented a small number of genes upregulated by both hypoxia and SMM. HIF1A knockdown and EPAS1 knockdown produced distinct, often opposing, effects on hypoxia-responsive pathways. HIF1A dominated upregulation of glycolytic pathway signalling. EPAS1 regulated genes that increase mucus concentration under hypoxia ( e.g. , SCNN1G ). An EPAS1 inhibitor blocked hypoxia-induced upregulation of Na + transport.

Conclusion

Chronic hypoxia and inflammation regulated distinct genes/pathways that combine to produce a complex diseased environment in muco-obstructed airway epithelia. HIF1A and EPAS1 regulated distinct hypoxia-induced transcriptional responses. EPAS1 inhibition may exhibit a favourable therapeutic ratio for treatment of muco-obstructive lung diseases.

Autor:innen und Institutionen

  • Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, , USA.
  • Department of Respiratory Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Contributes equally.
  • Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC, , USA.
  • Division of Pulmonary Medicine, Department of Medicine, Keio University, School of Medicine, Tokyo, Japan.
  • Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, , USA richard_boucher@med.unc.edu.

ORCID-Profile: Yu Mikami, Ella Burns, Takanori Asakura, Martina Gentzsch, Carla M P Ribeiro, Wanda K O'Neal

Förderung

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Japan Agency for Medical Research and Development
  • National Center for Advancing Translational Sciences
  • Japan Society for the Promotion of Science
  • Cystic Fibrosis Foundation
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Mikami, Y., Burns, E., Dang, H., van Heusden, C., Caldwell, R. A., Reidel, B., Furusho, M., Murano, H., Asakura, T., Gentzsch, M., Kesimer, M., Okuda, K., Ribeiro, C. M. P., Randell, S. H., O'Neal, W. K., & Boucher, R. C. (2026). Muco-obstructive lung disease exhibits distinct hypoxic and inflammatory airway epithelial gene pathways. European Respiratory Journal, 2502798. https://doi.org/10.1183/13993003.02798-2025

Vancouver

Mikami Y, Burns E, Dang H, van Heusden C, Caldwell RA, Reidel B, et al. Muco-obstructive lung disease exhibits distinct hypoxic and inflammatory airway epithelial gene pathways. European Respiratory Journal. 2026:2502798. doi:10.1183/13993003.02798-2025

BibTeX
@article{Mikami2026,
  author = {Mikami, Yu and Burns, Ella and Dang, Hong and van Heusden, Catharina and Caldwell, Ray A and Reidel, Boris and Furusho, Minako and Murano, Hiroaki and Asakura, Takanori and Gentzsch, Martina and Kesimer, Mehmet and Okuda, Kenichi and Ribeiro, Carla M P and Randell, Scott H and O'Neal, Wanda K and Boucher, Richard C},
  title = {Muco-obstructive lung disease exhibits distinct hypoxic and inflammatory airway epithelial gene pathways},
  journal = {European Respiratory Journal},
  year = {2026},
  pages = {2502798},
  doi = {10.1183/13993003.02798-2025}
}
Kostenlos starten →